INTRODUCTION
Pancreatic pseudocysts are classified as acute or chronic depending on whether they developed immediately after acute pancreatitis1. The time interval between the onset of acute pancreatitis and discovery of pseudocysts has been 1-6 weeks, while in patients with chronic symptomatic pseudocysts no episode of acute pancreatitis can be found. Most pseudocysts are acute (40-75%) with a spontaneous resolution frequency up to 400/02, whereas 25-60% are chronic pseudocysts with a minimal (3%) spontaneous resolution rate3. Because of the considerable complication rate, active management has been recommended for pseudocvsts over 
RESULTS
The success rate in access of the pancreatic duct was 15 out of 18 cases (83%), with only one technical failure in cannulation (1/18 6%). The respective success rate in selective bil-duct cannulation was 12 out of 18 cases (67%), with four technical failures (22%).
The pseudocysts were distributed into various types as shown in Table 2 . Over half (8/15) had main duct stenosis between the pseudocyst and papillary orifice. The distribution of the method of therapy is shown in Table 3 . Combined externalinternal drainage was performed by percutaneous transgastric drainage of the pseudocyst with side-holes of the catheter in the stomach. However, no initial decrease in pseudocyst size was observed upon keeping the catheter closed for external drainage. It was thereafter opened, and started to work. Therefore the case is here classified in the group of external drainage.
No haemorrhagic or septic complications occurred. One patient developed pancreatocutaneous fistula after percutaneous external drainage. The fistula closed spontaneously but recurrent pseudocyst soon followed. Three further pseudocyst recurrences took place. Total recurrence incidence was 27%. In the 12 cholangiograms gall-bladder stones were found once. In another case an "open" papillary orifice was seen in duodenoscopy, giving suggestion of a "passed stone"; in biliary radiography no further abnormalities were found.
ERCP-related complications such as septicaemia, acute phase pancreatitis, cholangitis etc. were never found.
DISCUSSION
The total number of pancreatic pseudocysts treated in our hospital in the study period was 19 ERCP has been considered important in pseudocyst patients for the investigation of the biliary tract3. Biliary pathology has been reported in over half of these cases7.
The smaller frequency (17%) of biliary pathology here may be due to the overwhelming preponderance of alcohol aetiology.
After the introduction of percutaneous needle aspirations '2 and percutaneous external drainage 13 of pseudocysts we became enthusiasts about this kind of therapy, which is minimally burdensome to the patient. The results in these reports were surprisingly good in the light of the 24-36% pseudocyst recurrence rate after surgical 14 16 external drainage
More recently, less encouraging results have been published, with a recurrence rate of up to 47/o 8'7. Here, the respective figure was 50%.
All the present recurrences (one with preceding fistula) occurred in the external drainage group. Moreover, all fell into the Type III category. It may easily be imagined that the pancreas behind the ductal stenosis is secreting towards the pseudocyst. If a canal is opened from the pseudocyst, the secretion continues into the intestinal canal in cases of internal drainage and outside the body in the form of pancreatic fistula in the cases of external drainage. Closure of the internal or external fistula is then followed by recurrent pseudocyst without recurrence after external drainage. This 
